SORD anticorps (N-Term)
Aperçu rapide pour SORD anticorps (N-Term) (ABIN926669)
Antigène
Voir toutes SORD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- SORD antibody was raised in rabbit using the N terminal of SORD as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
SORD Blocking Peptide, (ABIN936895), is also available for use as a blocking control in assays to test for specificity of this SORD antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SORD (Sorbitol Dehydrogenase (SORD))
-
Autre désignation
- SORD
-
Sujet
- Sorbitol dehydrogenase catalyzes the interconversion of polyols and their corresponding ketoses, and together with aldose reductase, makes up the sorbitol pathway that is believed to play an important role in the development of diabetic complications. The first reaction of the pathway (also called the polyol pathway) is the reduction of glucose to sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes the sorbitol to fructose using NAD(+) cofactor. Synonyms: Polyclonal SORD antibody, Anti-SORD antibody, sorbitol dehydrogenase antibody, SORD1 antibody.
Antigène
-